...
首页> 外文期刊>Cell Communication and Signaling >Gut ghrelin regulates hepatic glucose production and insulin signaling via a gut-brain-liver pathway
【24h】

Gut ghrelin regulates hepatic glucose production and insulin signaling via a gut-brain-liver pathway

机译:肠胃ghrelin通过肠-脑-肝途径调节肝葡萄糖生成和胰岛素信号传导

获取原文
           

摘要

Ghrelin modulates many physiological processes. However, the effects of intestinal ghrelin on hepatic glucose production (HGP) are still unclear. The current study was to explore the roles of intestinal ghrelin on glucose homeostasis and insulin signaling in the liver. The system of intraduodenal infusion and intracerebral microinfusion into the nucleus of the solitary tract (NTS) in the normal chow-diet rats and pancreatic-euglycemic clamp procedure (PEC) combined with [3-3H] glucose as a tracer were used to analyze the effect of intestinal ghrelin. Intraduodenal co-infusion of ghrelin, tetracaine and Activated Protein Kinase (AMPK) activator (AICAR), or pharmacologic and molecular inhibitor of N-methyl-D-aspartate receptors within the dorsal vagal complex, or hepatic vagotomy in rats were used to explore the possible mechanism of the effect of intestinal ghrelin on HGP. Our results demonstrated that gut infusion of ghrelin inhibited duodenal AMP-dependent protein kinase (AMPK) signal pathways, increased HGP and expression of gluconeogenic enzymes, and decreased insulin signaling in the liver of the rat. Intraduodenal co-infusion of ghrelin receptor antagonist [D-Lys3]-GHRP-6 and AMPK agonist with ghrelin diminished gut ghrelin-induced increase in HGP and decrease in glucose infusion rate (GIR) and hepatic insulin signaling. The effects of gut ghrelin were also negated by co-infusion with tetracaine, or MK801, an N-methyl-D-aspartate (NMDA) receptor inhibitor, and adenovirus expressing the shRNA of NR1 subunit of NMDA receptors (Ad-shNR1) within the dorsal vagal complex, and hepatic vagotomy in rats. When ghrelin and lipids were co-infused into the duodenum, the roles of gut lipids in increasing the rate of glucose infusion (GIR) and lowering HGP were reversed. The current study provided evidence that intestinal ghrelin has an effect on HGP and identified a neural glucoregulatory function of gut ghrelin signaling.
机译:生长激素释放激素调节许多生理过程。但是,肠生长激素释放肽对肝葡萄糖生成(HGP)的影响仍不清楚。当前的研究是探索小肠生长激素释放肽对肝脏葡萄糖稳态和胰岛素信号传导的作用。十二指肠正常饮食大鼠的十二指肠内输注和脑内微输注系统(NTS)和胰高血糖钳夹程序(PEC)结合[3-3H]葡萄糖作为示踪剂进行分析。肠生长激素释放肽的作用。用十二指肠内共注射生长素释放肽,丁卡因和活化蛋白激酶(AMPK)激活剂(AICAR)或背迷走神经复合物内的N-甲基-D-天冬氨酸受体的药理和分子抑制剂或大鼠进行肝迷走神经切断术ghrelin对HGP影响的可能机制。我们的研究结果表明,ghrelin的肠道输注抑制了大鼠肝脏中十二指肠AMP依赖的蛋白激酶(AMPK)信号通路,HGP和糖原异生酶的表达增加以及胰岛素信号的降低。十二指肠内ghrelin受体拮抗剂[D-Lys3] -GHRP-6和AMPK激动剂与ghrelin的共同输注减少了肠道中ghrelin诱导的HGP的升高,并降低了葡萄糖输注速率(GIR)和肝胰岛素信号传导。通过与丁卡因或NK-甲基-D-天冬氨酸(NMDA)受体抑制剂MK801以及在NMDA受体内表达NMDA受体NR1亚基的shRNA(Ad-shNR1)的腺病毒共输注,也可以消除肠生长激素释放肽的作用。背迷走神经复合体和大鼠肝迷走神经切断术。当将生长素释放肽和脂质共注入十二指肠时,肠道脂质在增加葡萄糖输注速率(GIR)和降低HGP中的作用被逆转。当前的研究提供了证据,表明肠道生长激素释放肽对HGP有影响,并确定了肠道生长激素释放肽信号传导的神经糖调节功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号